253 related articles for article (PubMed ID: 18338820)
1. Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.
Le Gallo M; Toutirais O; Montier T; Cabillic F; Bouet F; Delépine P; Lehn P; Jotereau F; Catros V
J Gene Med; 2008 Jun; 10(6):628-36. PubMed ID: 18338820
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
[TBL] [Abstract][Full Text] [Related]
3. Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.
Markowicz S; Niedzielska J; Kruszewski M; Ołdak T; Gajkowska A; Machaj EK; Skurzak H; Pojda Z
Acta Biochim Pol; 2006; 53(1):203-12. PubMed ID: 16404477
[TBL] [Abstract][Full Text] [Related]
4. CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.
Lohmann S; Galle K; Knop J; Enk AH
Cancer Gene Ther; 2000 Apr; 7(4):605-14. PubMed ID: 10811479
[TBL] [Abstract][Full Text] [Related]
5. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
7. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
[TBL] [Abstract][Full Text] [Related]
8. In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
Hasegawa K; Noguchi Y; Koizumi F; Uenaka A; Tanaka M; Shimono M; Nakamura H; Shiku H; Gnjatic S; Murphy R; Hiramatsu Y; Old LJ; Nakayama E
Clin Cancer Res; 2006 Mar; 12(6):1921-7. PubMed ID: 16551878
[TBL] [Abstract][Full Text] [Related]
9. Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.
Slager EH; van der Minne CE; Goudsmit J; van Oers JM; Kostense S; Havenga MJ; Osanto S; Griffioen M
Cancer Gene Ther; 2004 Mar; 11(3):227-36. PubMed ID: 14726960
[TBL] [Abstract][Full Text] [Related]
10. Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.
Batchu RB; Moreno AM; Szmania SM; Bennett G; Spagnoli GC; Ponnazhagan S; Barlogie B; Tricot G; van Rhee F
Cancer Res; 2005 Nov; 65(21):10041-9. PubMed ID: 16267030
[TBL] [Abstract][Full Text] [Related]
11. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization.
Irvine AS; Trinder PK; Laughton DL; Ketteringham H; McDermott RH; Reid SC; Haines AM; Amir A; Husain R; Doshi R; Young LS; Mountain A
Nat Biotechnol; 2000 Dec; 18(12):1273-8. PubMed ID: 11101806
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
Rodolfo M; Luksch R; Stockert E; Chen YT; Collini P; Ranzani T; Lombardo C; Dalerba P; Rivoltini L; Arienti F; Fossati-Bellani F; Old LJ; Parmiani G; Castelli C
Cancer Res; 2003 Oct; 63(20):6948-55. PubMed ID: 14583496
[TBL] [Abstract][Full Text] [Related]
13. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.
Van Tendeloo VF; Snoeck HW; Lardon F; Vanham GL; Nijs G; Lenjou M; Hendriks L; Van Broeckhoven C; Moulijn A; Rodrigus I; Verdonk P; Van Bockstaele DR; Berneman ZN
Gene Ther; 1998 May; 5(5):700-7. PubMed ID: 9797876
[TBL] [Abstract][Full Text] [Related]
14. Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
Held G; Matsuo M; Epel M; Gnjatic S; Ritter G; Lee SY; Tai TY; Cohen CJ; Old LJ; Pfreundschuh M; Reiter Y; Hoogenboom HR; Renner C
Eur J Immunol; 2004 Oct; 34(10):2919-29. PubMed ID: 15368308
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
16. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K
J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635
[TBL] [Abstract][Full Text] [Related]
17. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.
Denis-Mize KS; Dupuis M; MacKichan ML; Singh M; Doe B; O'Hagan D; Ulmer JB; Donnelly JJ; McDonald DM; Ott G
Gene Ther; 2000 Dec; 7(24):2105-12. PubMed ID: 11223992
[TBL] [Abstract][Full Text] [Related]
19. Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
Hu Y; Cheng SC; Chan KT; Ke Y; Xue B; Sin FW; Zeng C; Xie Y
Biochem Biophys Res Commun; 2010 Feb; 392(3):329-34. PubMed ID: 20067767
[TBL] [Abstract][Full Text] [Related]
20. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
Melhem NM; Liu XD; Boczkowski D; Gilboa E; Barratt-Boyes SM
Eur J Immunol; 2007 Aug; 37(8):2164-73. PubMed ID: 17615585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
